FDA Registration
Active
🇺🇸 United States
mAb P.vivax LDH
Reg #: 3032562
·
FEI: 3002606748
·
Expires 2025
Products
1
Proprietary Names
9
Establishment Types
1
Classifications
1
Registration Details
- Registration Name
- INBIOS INTERNATIONAL, INC.
- Registration Number
- 3032562
- FEI Number
- 3002606748
- Status
- Active
- Expiry Year
- 2025
- Initial Importer
- No
- Address
- 307 Westlake Ave North, Suite 300
- City
- Seattle
- State
- WA
- ZIP
- 98109
- Country
- US
Owner / Operator
- Firm Name
- INBIOS INTERNATIONAL, INC.
- Operator Number
- 9032122
- Address
- 307 Westlake Ave North, Suite 300
- City
- Seattle
- State
- WA
- Postal Code
- 98109
- Country
- US
- Correspondent
- ESTELA I RAYCHAUDHURI
Products
| Device Name | Product Code | Device Class | Medical Specialty | Exempt | Created |
|---|---|---|---|---|---|
| Reagents, Specific, Analyte | MVU | Class 1 | Pathology | No | 2006-11-09 |
Proprietary Names
mAb P.vivax LDH
1:100 Diluted 6B6C-1/HRP Conjugate
ITC 8.2 Purified Antigen
Chikungunya Antigen for IgG
RTU NCA for Dengue IgM
Undiluted 6B6C-1/HRP Conjugate
Ready to Use Enzyme Conjugate-HRP for West Nile IgM
RTU Dengue Antigen for IgM (DENRA)
mAb P.falciparum, ovale, vivax LDH
Establishment Types
Manufacture Medical Device